ResMed | RMD - Pre Tax Profit


ResMed reported $502.31M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Ansell USD 126.7M 93.35M Dec/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD 362M 368M Jun/2026
Cochlear AUD 121.1M 155.6M Jun/2025
Cooper Companies USD 192.2M 75.4M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Dexcom USD 269.5M 71.2M Mar/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
Fisher Paykel Healthcare NZD 347.7M 50.8M Jun/2026
Globus Medical USD 157.07M 12.16M Mar/2026
Haemonetics USD 47.57M 75.97M Jun/2026
Idexx Laboratories USD 417.22M 61.78M Jun/2026
Inogen USD -6.06M 467K Sep/2024
Insulet USD 118.7M 5.7M Jun/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 940.4M 15.2M Mar/2026
Medtronic USD 2.45B 1.04B Mar/2026
Philips EUR 546M 356M Jun/2026
Ramsay Health Care AUD 240.5M 136.75M Dec/2025
ResMed USD 502.31M 6.16M Mar/2026
Sigma Healthcare AUD 8.15M 7.4M Jul/2024
Sonic Healthcare AUD 402.01M 53.16M Jun/2025
Steris USD 304.5M 46.7M Mar/2026
Teleflex USD -3.83M 222.77M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026